CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Share-based Payment Arrangement, Expense
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Share-based Payment Arrangement, Expense of $71.08 million for the 12-month period ending 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-02-18
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense for the quarter ending 2021-12-25 was $19.18M, a 24.84% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense for the quarter ending 2021-09-25 was $22.02M, a 30.55% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense for the quarter ending 2021-06-26 was $17.08M, a 29.93% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense for the quarter ending 2021-03-27 was $13.19M, a 20.34% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense for fiscal 2025 was $71.08M, a 1.71% increase from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense for fiscal 2024 was $69.89M, a 2.99% decline from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense for fiscal 2023 was $72.05M, a 2.13% decline from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense for fiscal 2022 was $73.62M, a 3.00% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|---|
| 2025-12-27 | $71.08M 10-K · filed 2026-02-18 | |||||
| 2024-12-28 | $69.89M 10-K · filed 2026-02-18 | |||||
| 2023-12-30 | $72.05M 10-K · filed 2026-02-18 | |||||
| 2022-12-31 | $73.62M 10-K · filed 2025-02-19 | |||||
| 2021-12-25 | $19.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $41.21M derived: sum of 2 quarters · filed 2024-02-14 | $58.28M derived: sum of 3 quarters · filed 2024-02-14 | $71.47M 10-K · filed 2024-02-14 | ||
| 2021-09-25 | $22.02M 10-Q · filed 2021-11-03 | $39.10M derived: sum of 2 quarters · filed 2021-11-03 | $52.29M 10-Q · filed 2021-11-03 | $67.66M derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2021-06-26 | $17.08M 10-Q · filed 2021-08-04 | $30.27M 10-Q · filed 2021-08-04 | $45.63M derived: sum of 3 quarters · filed 2023-02-22 | $62.50M derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2021-03-27 | $13.19M 10-Q · filed 2021-05-04 | $28.56M derived: sum of 2 quarters · filed 2023-02-22 | $45.43M derived: sum of 3 quarters · filed 2023-02-22 | $58.57M derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2020-12-26 | $15.37M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $32.24M derived: sum of 2 quarters · filed 2023-02-22 | $45.38M derived: sum of 3 quarters · filed 2023-02-22 | $56.34M 10-K · filed 2023-02-22 | ||
| 2020-09-26 | $16.87M 10-Q · filed 2021-11-03 | $30.01M derived: sum of 2 quarters · filed 2021-11-03 | $40.97M 10-Q · filed 2021-11-03 | $54.81M derived: sum of 4 quarters · filed 2022-02-16 | ||
| 2020-06-27 | $13.14M 10-Q · filed 2021-08-04 | $24.10M 10-Q · filed 2021-08-04 | $37.95M derived: sum of 3 quarters · filed 2022-02-16 | $51.97M derived: sum of 4 quarters · filed 2022-02-16 | ||
| 2020-03-28 | $10.96M 10-Q · filed 2021-05-04 | $24.80M derived: sum of 2 quarters · filed 2022-02-16 | $38.83M derived: sum of 3 quarters · filed 2022-02-16 | $55.33M derived: sum of 4 quarters · filed 2022-02-16 | ||
| 2019-12-28 | $13.84M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $27.87M derived: sum of 2 quarters · filed 2022-02-16 | $44.37M derived: sum of 3 quarters · filed 2022-02-16 | $57.27M 10-K · filed 2022-02-16 | ||
| 2019-09-28 | $14.03M 10-Q · filed 2020-10-29 | $30.53M derived: sum of 2 quarters · filed 2020-10-29 | $43.43M 10-Q · filed 2020-10-29 | $54.87M derived: sum of 4 quarters · filed 2021-02-17 | ||
| 2019-06-29 | $16.50M 10-Q · filed 2020-08-05 | $29.40M 10-Q · filed 2020-08-05 | $40.84M derived: sum of 3 quarters · filed 2021-02-17 | $52.66M derived: sum of 4 quarters · filed 2021-02-17 | ||
| 2019-03-30 | $12.90M 10-Q · filed 2020-05-07 | $24.34M derived: sum of 2 quarters · filed 2021-02-17 | $36.16M derived: sum of 3 quarters · filed 2021-02-17 | $49.70M derived: sum of 4 quarters · filed 2021-02-17 | ||
| 2018-12-29 | $11.44M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $23.26M derived: sum of 2 quarters · filed 2021-02-17 | $36.80M derived: sum of 3 quarters · filed 2021-02-17 | $47.35M 10-K · filed 2021-02-17 | ||
| 2018-09-29 | $11.82M 10-Q · filed 2019-11-06 | $25.37M derived: sum of 2 quarters · filed 2019-11-06 | $35.91M 10-Q · filed 2019-11-06 | $47.01M derived: sum of 4 quarters · filed 2020-02-11 | ||
| 2018-06-30 | $13.55M 10-Q · filed 2019-07-31 | $24.09M 10-Q · filed 2019-07-31 | $35.19M derived: sum of 3 quarters · filed 2020-02-11 | $46.72M derived: sum of 4 quarters · filed 2020-02-11 | ||
| 2018-03-31 | $10.54M 10-Q · filed 2019-05-07 | $21.64M derived: sum of 2 quarters · filed 2020-02-11 | $33.17M derived: sum of 3 quarters · filed 2020-02-11 | $45.06M derived: sum of 4 quarters · filed 2020-02-11 | ||
| 2017-12-30 | $11.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11 | $22.63M derived: sum of 2 quarters · filed 2020-02-11 | $34.52M derived: sum of 3 quarters · filed 2020-02-11 | $44.00M 10-K · filed 2020-02-11 | ||
| 2017-09-30 | $11.53M 10-Q · filed 2018-11-07 | $23.42M derived: sum of 2 quarters · filed 2018-11-07 | $32.90M 10-Q · filed 2018-11-07 | $43.90M derived: sum of 4 quarters · filed 2019-02-13 | ||
| 2017-07-01 | $11.89M 10-Q · filed 2018-08-08 | $21.38M 10-Q · filed 2018-08-08 | $32.37M derived: sum of 3 quarters · filed 2019-02-13 | $42.97M derived: sum of 4 quarters · filed 2019-02-13 | ||
| 2017-04-01 | $9.49M 10-Q · filed 2018-05-10 | $20.48M derived: sum of 2 quarters · filed 2019-02-13 | $31.08M derived: sum of 3 quarters · filed 2019-02-13 | $43.19M derived: sum of 4 quarters · filed 2019-02-13 | ||
| 2016-12-31 | $10.99M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $21.59M derived: sum of 2 quarters · filed 2019-02-13 | $33.70M derived: sum of 3 quarters · filed 2019-02-13 | $43.64M 10-K · filed 2019-02-13 | ||
| 2016-09-24 | $10.60M 10-Q · filed 2017-11-09 | $22.71M derived: sum of 2 quarters · filed 2017-11-09 | $32.65M 10-Q · filed 2017-11-09 | $42.42M derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2016-06-25 | $12.11M 10-Q · filed 2017-08-09 | $22.05M 10-Q · filed 2017-08-09 | $31.82M derived: sum of 3 quarters · filed 2018-02-13 | $42.30M derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2016-03-26 | $9.94M 10-Q · filed 2017-05-10 | $19.71M derived: sum of 2 quarters · filed 2018-02-13 | $30.19M derived: sum of 3 quarters · filed 2018-02-13 | $40.39M derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2015-12-26 | $9.77M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $20.25M derived: sum of 2 quarters · filed 2018-02-13 | $30.45M derived: sum of 3 quarters · filed 2018-02-13 | $40.12M 10-K · filed 2018-02-13 | ||
| 2015-09-26 | $10.48M 10-Q · filed 2016-11-02 | $20.68M derived: sum of 2 quarters · filed 2016-11-02 | $30.35M 10-Q · filed 2016-11-02 | $38.25M derived: sum of 4 quarters · filed 2017-02-14 | ||
| 2015-06-27 | $10.20M 10-Q · filed 2016-08-03 | $19.87M 10-Q · filed 2016-08-03 | $27.78M derived: sum of 3 quarters · filed 2017-02-14 | $36.03M derived: sum of 4 quarters · filed 2017-02-14 | ||
| 2015-03-28 | $9.67M 10-Q · filed 2016-05-04 | $17.58M derived: sum of 2 quarters · filed 2017-02-14 | $25.83M derived: sum of 3 quarters · filed 2017-02-14 | $34.05M derived: sum of 4 quarters · filed 2017-02-14 | ||
| 2014-12-27 | $7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $16.15M derived: sum of 2 quarters · filed 2017-02-14 | $24.38M derived: sum of 3 quarters · filed 2017-02-14 | $31.04M 10-K · filed 2017-02-14 | ||
| 2014-09-27 | $8.25M 10-Q · filed 2015-11-04 | $16.47M derived: sum of 2 quarters · filed 2015-11-04 | $23.13M 10-Q · filed 2015-11-04 | $29.44M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2014-06-28 | $8.22M 10-Q · filed 2015-07-30 | $14.88M 10-Q · filed 2015-07-30 | $21.19M derived: sum of 3 quarters · filed 2016-02-12 | $27.24M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2014-03-29 | $6.66M 10-Q · filed 2015-04-30 | $12.97M derived: sum of 2 quarters · filed 2016-02-12 | $19.02M derived: sum of 3 quarters · filed 2016-02-12 | $25.30M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2013-12-28 | $6.31M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $12.36M derived: sum of 2 quarters · filed 2016-02-12 | $18.64M derived: sum of 3 quarters · filed 2016-02-12 | $24.54M 10-K · filed 2016-02-12 | ||
| 2013-09-28 | $6.05M 10-Q · filed 2014-10-30 | $12.33M derived: sum of 2 quarters · filed 2014-10-30 | $18.23M 10-Q · filed 2014-10-30 | $18.23M 10-Q · filed 2013-10-30 | $24.26M derived: sum of 4 quarters · filed 2015-02-17 | |
| 2013-06-29 | $6.28M 10-Q · filed 2014-08-07 | $12.18M 10-Q · filed 2014-08-07 | $12.19M 10-Q · filed 2013-07-31 | $18.21M derived: sum of 3 quarters · filed 2015-02-17 | $23.45M derived: sum of 4 quarters · filed 2015-02-17 | |
| 2013-03-30 | $5.90M 10-Q · filed 2014-04-30 | $11.93M derived: sum of 2 quarters · filed 2015-02-17 | $17.17M derived: sum of 3 quarters · filed 2015-02-17 | $22.49M derived: sum of 4 quarters · filed 2015-02-17 | ||
| 2012-12-29 | $6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $11.27M derived: sum of 2 quarters · filed 2015-02-17 | $16.59M derived: sum of 3 quarters · filed 2015-02-17 | $21.86M 10-K · filed 2015-02-17 | ||
| 2012-09-29 | $5.24M 10-Q · filed 2013-10-30 | $10.56M derived: sum of 2 quarters · filed 2013-10-30 | $15.83M 10-Q · filed 2013-10-30 | $20.61M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-06-30 | $5.32M 10-Q · filed 2013-07-31 | $10.59M 10-Q · filed 2013-07-31 | $15.37M derived: sum of 3 quarters · filed 2014-02-25 | $20.95M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-03-31 | $5.27M 10-Q · filed 2013-05-08 | $10.05M derived: sum of 2 quarters · filed 2014-02-25 | $15.62M derived: sum of 3 quarters · filed 2014-02-25 | $21.05M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2011-12-31 | $4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $10.36M derived: sum of 2 quarters · filed 2014-02-25 | $15.79M derived: sum of 3 quarters · filed 2014-02-25 | $21.71M 10-K · filed 2014-02-25 | ||
| 2011-09-24 | $5.57M 10-Q · filed 2012-11-01 | $11.00M derived: sum of 2 quarters · filed 2012-11-01 | $16.92M 10-Q · filed 2012-11-01 | $21.00M derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2011-06-25 | $5.43M 10-Q · filed 2012-08-07 | $11.35M 10-Q · filed 2012-08-07 | $15.43M derived: sum of 3 quarters · filed 2013-02-27 | $22.20M derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2011-03-26 | $5.92M 10-Q · filed 2012-05-04 | $10.00M derived: sum of 2 quarters · filed 2013-02-27 | $16.77M derived: sum of 3 quarters · filed 2013-02-27 | $24.48M derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2010-12-25 | $4.08M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $10.85M derived: sum of 2 quarters · filed 2013-02-27 | $18.57M derived: sum of 3 quarters · filed 2013-02-27 | $25.53M 10-K · filed 2013-02-27 | ||
| 2010-09-25 | $6.77M 10-Q · filed 2011-11-02 | $14.48M derived: sum of 2 quarters · filed 2011-11-02 | $21.44M 10-Q · filed 2011-11-02 | |||
| 2010-06-26 | $7.71M 10-Q · filed 2011-08-03 | $14.57M 10-Q · filed 2011-08-03 | ||||
| 2009-12-26 | $23.65M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |